Regarding THBS1, this anti-angiogenic molecule seems to be involved in the pathophysiology of hypoxia-induced pulmonary hypertension and right ventricular hypertrophy (Ochoa et al., 2010; Bauer et al., 2012; Rogers et al., 2017). Here, THBS1 is linked to pulmonary hypertension.